Dipal Doshi's Net Worth
Dipal Doshi's net worth is estimated to be at least $984,474.99 as of 11/23/2024. CoreStreet's estimation of Dipal Doshi's net worth is based on their sale of stock and current holding of stock.
Dipal Doshi is CEO at Entrada Therapeutics Inc. They have executed at least 33 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,600 units of TRDA stock on 07/15/2024. Their biggest sale was on 12/27/2022 when they sold 9,669 units of Entrada Therapeutics Inc stock for $145,228.38. They typically trade 8 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $984,474.99
Most recent insider trade:
- July 15, 2024
Dipal Doshi's Insider Trading History
| Entrada Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 15, 2024 | CEO | 1,600 | $17.81 | Sell | $28,496.00 |
July 12, 2024 | CEO | 300 | $18.00 | Sell | $5,400.00 |
June 13, 2024 | CEO | 1,000 | $16.17 | Sell | $16,170.00 |
May 16, 2024 | CEO | 1,800 | $15.00 | Sell | $27,000.00 |
Feb. 15, 2024 | CEO | 1,000 | $15.00 | Sell | $15,000.00 |
Jan. 16, 2024 | CEO | 1,000 | $15.99 | Sell | $15,990.00 |
Dec. 20, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 |
Nov. 13, 2023 | CEO | 1,000 | $16.23 | Sell | $16,230.00 |
Oct. 17, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 |
Sept. 13, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 |
Aug. 14, 2023 | CEO | 1,000 | $15.67 | Sell | $15,670.00 |
April 27, 2023 | CEO | 2,000 | $13.71 | Sell | $27,420.00 |
April 17, 2023 | CEO | 2,092 | $18.01 | Sell | $37,676.92 |
March 27, 2023 | CEO | 2,000 | $14.72 | Sell | $29,440.00 |
Jan. 27, 2023 | CEO | 2,000 | $12.00 | Sell | $24,000.00 |
Jan. 9, 2023 | CEO | 2,410 | $15.02 | Sell | $36,198.20 |
Dec. 29, 2022 | CEO | 400 | $15.01 | Sell | $6,004.00 |
Dec. 27, 2022 | CEO | 9,669 | $15.02 | Sell | $145,228.38 |
Nov. 28, 2022 | CEO | 2,000 | $13.91 | Sell | $27,820.00 |
Oct. 27, 2022 | CEO | 2,000 | $21.66 | Sell | $43,320.00 |
Oct. 24, 2022 | CEO | 2,342 | $19.30 | Sell | $45,200.60 |
Oct. 20, 2022 | CEO | 811 | $18.01 | Sell | $14,606.11 |
Sept. 28, 2022 | CEO | 3,085 | $15.23 | Sell | $46,984.55 |
Sept. 26, 2022 | CEO | 3,083 | $15.32 | Sell | $47,231.56 |
Sept. 23, 2022 | CEO | 1,023 | $15.07 | Sell | $15,416.61 |
Sept. 21, 2022 | CEO | 3,402 | $15.12 | Sell | $51,438.24 |
Sept. 15, 2022 | CEO | 200 | $15.04 | Sell | $3,008.00 |
Sept. 8, 2022 | CEO | 1,100 | $15.16 | Sell | $16,676.00 |
Aug. 31, 2022 | CEO | 171 | $12.00 | Sell | $2,052.00 |
Aug. 29, 2022 | CEO | 1,639 | $12.88 | Sell | $21,110.32 |
July 27, 2022 | CEO | 2,000 | $12.00 | Sell | $24,000.00 |
June 27, 2022 | CEO | 4,000 | $12.00 | Sell | $48,000.00 |
| Amicus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 8, 2015 | SVP | 6,250 | $13.87 | Sell | $86,687.50 |